Search
for
Sort by
Research 31–60 of 1000+
- Haemostatic and Biocompatibility Evaluation of Alginate-Functionalized Polylactide Composite Containing Zinc Sulphide and Hardystonite
- Drug-Induced Skin, Nail and Hair Disorders
- Drug-Induced Hair Loss and Hair Growth
- Antiulcer drugs
- Drug-induced changes in hair growth
- Agent specific effects of anticoagulant induced alopecia
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Antihelminthic Drugs
- Cutaneous drug reactions
- DRUG‐ASSOCIATED ALOPECIA
- 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D3 analogue in humans
- Drug-Induced Hair Disorders
- Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries
- Anticoagulant-free preparation of autologous platelet-rich plasma (PRP) / fluid platelet-rich fibrin (f-PRF): a pre-clinical comparative performance study
- New Drugs: Dutasteride
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Drug eruptions in dermatology
- An overview of management of drug-induced hair and nail disorders
- Discovery of New Drug Therapies Based on the Study of Adverse Reactions
- ESTUDO DA TECNOLOGIA PULSE BOOSTER DRUG DELIVERY MESOJECTGUN® E SEUS RESULTADOS NA REGIÃO CAPILAR
- Psychotropic Medication and Drug-Related Alopecia
- Evaluation of the efficacy of transdermal drug delivery of calcipotriol plus betamethasone versus tacrolimus in the treatment of vitiligo
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Investigation of the effect of anticoagulants on platelet recovery, enrichment factor, PDGF, TGF-β1 and optimal dose in the preparation of platelet-rich plasma
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Rivaroxaban-induced hair loss
- Enoxaparin-induced alopecia in patients with cerebral venous thrombosis
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Imported cutaneous Leishmaniasis in Japan
- Cyclosporine-Induced Alopecia in Childhood Nephrotic Syndrome – A Case Report